Client Management | Digital KYC | Transactions | Investor App | AUM & Brokerage Reports | Lead Management | Automated Follow-Ups | MF Research | Multi-Asset Tracking
Login
Get Started
Home Mf Research Pgim India Healthcare Fund Regular Plan Growth
PGIM INDIA MUTUAL FUND

Mutual Fund Research

PGIM India Healthcare Fund - Regular Plan - Growth

PGIM INDIA MUTUAL FUND Equity Equity Sectoral Thematic

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,025.22 +2.52%
Two Week 2026-10-19 ₹1,000.00 ₹1,046.14 +4.61%
One Month 2026-10-05 ₹1,000.00 ₹1,004.26 +0.43%
Three Months 2026-08-05 ₹3,000.00 ₹2,958.69 -1.38%
Six Months 2026-05-07 ₹6,000.00 ₹6,198.98 +3.32%
One Year 2025-11-03 ₹12,000.00 ₹13,454.26 +12.12%
Since Inception 2024-12-06 ₹24,000.00 ₹27,943.96 +16.43%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 62.79%
Healthcare Services 24.57%
Other 5.11%
Chemicals & Petrochemicals 3.24%
Insurance 2.10%
Retailing 0.99%
Healthcare Equipment & Supplies 0.80%
IT - Services 0.40%

Top Holdings

Company-wise portfolio exposure

Divi's Laboratories Ltd. 10.36%
Sun Pharmaceutical Industries Ltd. 10.25%
Torrent Pharmaceuticals Ltd. 8.49%
Ajanta Pharma Ltd. 4.96%
Max Healthcare Institute Ltd. 4.71%
Dr. Lal Path Labs Ltd. 4.33%
Mankind Pharma Ltd. 4.04%
Manipal Health Enterprises Ltd. 3.68%
Navin Fluorine International Ltd. 3.24%
Abbott India Ltd. 3.12%
Krishna Inst of Medical Sciences Ltd. 2.99%
Rubicon Research Ltd. 2.99%
Neuland Laboratories Ltd. 2.91%
Aster DM Quality Care Ltd. 2.56%
Sai Life Sciences Ltd 2.54%
ICICI Lombard General Insurance Co. Ltd. 2.10%
Cipla Ltd. 2.04%
Zydus Lifesciences Ltd. 2.04%
Lupin Ltd. 1.93%
IPCA Laboratories Ltd. 1.92%
Dr Agarwal's Eye Hospital Ltd. 1.86%
Anthem Biosciences Ltd. 1.81%
Global Health Ltd. 1.52%
Gland Pharma Ltd. 1.50%
Jupiter Life Line Hospitals Ltd. 1.46%
Fortis Healthcare Ltd. 1.46%
Symbiotec Pharmalab Ltd. 1.10%
Lenskart Solutions Ltd. 0.99%
Molbio Diagnostics Ltd. 0.80%
Orchid Pharma Ltd. 0.79%
Sagility Ltd. 0.40%
Clearing Corporation of India Ltd. 5.24%
Net Receivables / (Payables) -0.13%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
N/A
Return volatility
β
Beta
N/A
Benchmark sensitivity
S
Sharpe Ratio
N/A
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity
Risk ratio figures are currently unavailable for this scheme. Explanations below are for reference.

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Peer Comparison

Compare similar mutual funds by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Nippon India Taiwan Equity Fund - Regular Plan - Growth 59.11% 48.18% 22.89%
HDFC Pharma And Healthcare Fund - Regular Plan - Growth 22.21% 29.08% 28.07%
Kotak Healthcare Fund - Regular Plan - Growth 21.83% 0.00% 19.25%
ICICI Prudential US Bluechip Equity Fund - Regular Plan - Growth 20.17% 18.45% 15.90%
Nippon India - Japan Equity Fund - Regular Plan - Growth 20.05% 20.38% 8.48%
SBI Automotive Opportunities Fund - Regular Plan - Growth 18.72% 0.00% 10.86%
Mirae Asset Healthcare Fund - Regular Plan - Growth 17.38% 22.11% 20.05%
Whiteoak Capital - Pharma And Healthcare Fund - Regular Plan - Growth 17.07% 0.00% 20.11%
Bajaj Finserv Healthcare Fund - Regular Plan - Growth 16.66% 0.00% 8.50%
SBI Healthcare Opportunities Fund - Regular Plan - Growth 16.50% 23.22% 15.44%

Returns are historical and do not guarantee future performance.

View All Equity Sectoral Thematic Funds

Fund Family

Compare schemes from PGIM INDIA MUTUAL FUND by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
PGIM India Healthcare Fund - Regular Plan - Growth 16.27% 0.00% 9.01%
PGIM India Global Select Real Estate Securities Fund Of Fund - Regular Plan - Growth 11.73% 13.79% 4.93%
PGIM India Liquid Fund - Regular Plan - Growth 6.41% 6.81% 20.70%
PGIM India Emerging Markets Equity Fund Of Fund - Regular Plan - Growth 6.41% 19.35% 2.32%
PGIM India Arbitrage Fund - Regular Plan - Growth 5.99% 6.31% 5.75%
PGIM India Money Market Fund - Regular Plan - Growth 5.92% 6.81% 5.59%
PGIM India Small Cap Fund - Regular Plan - Growth 5.85% 13.16% 11.47%
PGIM India Ultra Short Term Fund - Regular Plan - Growth 5.51% 6.32% 5.80%
PGIM India Overnight Fund - Regular Plan - Growth 5.11% 5.91% 99.27%
PGIM India Corporate Bond Fund - Regular Plan - Growth 2.82% 6.14% 6.57%

Returns are historical and do not guarantee future performance.

View All PGIM INDIA MUTUAL FUND Funds

Scheme Objective

The investment mandate and purpose of this scheme

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.61%
Expense Ratio (Direct)
0.96%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare TRI

Exit Load

Charges that may apply when you redeem units

For Exits within 90 days from date of allotment of units: 0.50%; For Exits beyond 90 days from date of allotment of units: NIL.
Top AMC/Fund Houses
360 ONE Mutual Fund AMC logo
360 ONE Mutual Fund
AUM
₹13,053 Cr
Age
15+ Years
Aditya Birla Sun Life Mutual Fund AMC logo
Aditya Birla Sun Life Mutual Fund
AUM
₹4.36 Lakh Cr
Age
31+ Years
Helios Mutual Fund AMC logo
Helios Mutual Fund
AUM
₹9,401 Cr
Age
1–2 Years
Bandhan Mutual Fund AMC logo
Bandhan Mutual Fund
AUM
₹1.78+ Lakh Cr
Age
4 Years
view all

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?